Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,683,187
-$553,042 QoQ
Shares Held
786,536
-25.1% QoQ
Ownership
0.830%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 82 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARK Investment Management LLC holds $1,628,434,493 across 17 Biotechnology names. CGEN ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
9,460,939 | $515,999,613 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
10,234,862 | $351,260,463 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
16,875,684 | $285,536,573 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
41,337,632 | $151,709,109 | |
| 5 | ABSI |
Absci Corp
|
12,925,271 | $149,803,890 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,793,196 | $43,502,934 | |
| 7 | PRME |
Prime Medicine, Inc.
|
8,348,746 | $30,806,872 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
300,770 | $23,848,053 |
All Filings in CGEN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,683,187 | 786,536 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,236,229 | 1,049,873 | Shares | Sole | 2026-05-12 | |
| 2025-06-30 | $1,909,541 | 1,072,776 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,298,916 | 889,669 | Shares | Sole | 2025-05-07 | |
| 2024-09-30 | $1,976,851 | 1,092,183 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,828,295 | 1,088,271 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,681,373 | 1,039,292 | Shares | Sole | 2024-04-18 | |
| 2022-12-31 | $1,735,498 | 2,410,414 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $763,939 | 1,157,484 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $19,945,998 | 10,781,621 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $32,936,748 | 10,228,804 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $39,656,384 | 9,222,415 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $58,701,087 | 9,832,678 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $99,158,025 | 11,975,607 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $123,888,089 | 14,422,362 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $206,878,835 | 17,083,306 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $287,173,705 | 17,672,228 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $211,758,313 | 14,098,423 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $74,969,373 | 10,326,360 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||